MedTrace Logo

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

NCT05277740 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-11-09

No results posted yet for this study

Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by CIS and RRMS and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to identify which metrics-or combination thereof-can serve as reliable biomarker of CIS and RRMS disease progression and cognitive status.

Conditions

  • Clinically Isolated Syndrome
  • Relapsing Remitting Multiple Sclerosis

Interventions

DEVICE

Eye-tracking

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Sponsors & Collaborators

Principal Investigators

  • Paul S Giacomini, MD · McGill University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277740 on ClinicalTrials.gov